Kolexia
Juntas Morales Raul Neurologie
Juntas Morales Raul
Neurologie
Hôpital Gui de Chauliac
Montpellier, France
146 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sclérose latérale amyotrophique Maladies musculaires Sclérose Maladies du motoneurone Dystrophies musculaires Maladie de Charcot-Marie-Tooth COVID-19 Myasthénie Dystrophie musculaire facio-scapulo-humérale

Collaborateurs

Voir plus
Pageot Nicolas
Pageot Nicolas
Clinique Beau Soleil, Montpellier, France
Camu William
Camu William
Hôpital Gui de Chauliac, Montpellier, France
Cossee Mireille
Cossee Mireille
CHU Montpellier, Limoges, France
Esselin Florence
Esselin Florence
Hôpital Gui de Chauliac, Montpellier, France

Industries

Voir plus
Sanofi
4 collaboration(s)
Dernière en 2020
CSL Behring
1 collaboration(s)
Dernière en 2020
LFB
1 collaboration(s)
Dernière en 2020
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease.
Neurologia (Barcelona, Spain)   01 mars 2024
Objective evaluation of clinical actionability for genes involved in myopathies: 63 genes with a medical value for patient care
Abstracts from the 56th European Society of Human Genetics (ESHG) Conference   01 janvier 2024
OPALE: Observatoire Des Patients Atteints de Laminopathies et Emerinopathies (Observatory for PAtients With Laminopathies and Emerinopathies)
Essai Clinique (Hôpital Pitie Salpetriere)   13 décembre 2023
RAISE-XT: A Phase 3, Multicenter, Open-Label Extension Study of Zilucoplan in Subjects With Generalized Myasthenia Gravis
Essai Clinique (Ra Pharmaceuticals, Inc.)   07 décembre 2023
Heterozygous p.Leu39del is a major cause of slow-progressing juvenile ALS.
Journal of neurology, neurosurgery, and psychiatry   24 novembre 2023
Clinical Classification of Variants in the Valosin-Containing Protein Gene Associated With Multisystem Proteinopathy.
Neurology. Genetics   15 août 2023
RAISE: A Phase 3, Multicenter, Randomized, Double Blind, Placebo-Controlled Study to Confirm the Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis
Essai Clinique (Ra Pharmaceuticals, Inc.)   02 mai 2023
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
The Lancet. Neurology   18 avril 2023
Biofluid Biomarkers in the Prognosis of Amyotrophic Lateral Sclerosis: Recent Developments and Therapeutic Applications.
Cells   18 avril 2023
Distal hereditary motor neuropathy due to a novel YARS1 gene pathogenic variant.
Muscle & nerve   27 mars 2023